©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 7, 2026; 32(9): 114758
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.114758
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.114758
Table 1 Clinical characteristics
| Characteristics | ED + S (n = 21) | ED - S (n = 10) |
| Age (years) | 50 (13-77) | 46.4 (19-77) |
| Sex | ||
| Male | 8 (38.1) | 4 (40.0) |
| Female | 13 (61.9) | 6 (60.0) |
| BMI (kg/m2) | 20.4 (15.6-26) | 22.1 (16.9-27.8) |
| Ling classification | ||
| Ling IIIR | 11 (52.4) | 5 (50.0) |
| Ling IIIL | 8 (38.1) | 3 (30.0) |
| Ling IIILR | 2 (9.5) | 2 (20.0) |
| EMIA classification | ||
| A | 7 (33.3) | 4 (40.0) |
| B | 9 (42.9) | 4 (40.0) |
| C | 3 (14.3) | 1 (10.0) |
| D | 2 (9.5) | 1 (10.0) |
| SMF classification | ||
| A0 | 2 (9.5) | 0 |
| A1 | 9 (42.9) | 2 (20.0) |
| A2 | 9 (42.9) | 7 (70.0) |
| A3 | 1 (4.7) | 1 (10.0) |
| Disease course (months) | 109 (1-360) | 208 (16-840) |
| Patients with prior treatment | ||
| Pneumatic balloon dilation | 2 (9.5) | 0 |
| Botulinum toxin injection | 2 (9.5) | 1 (10.0) |
| Per-oral endoscopic myotomy | 1 (4.7) | 2 (20.0) |
| Heller myotomy | 0 | 4 (40.0) |
| Chicago classification | ||
| Type I | 3 (14.3) | 7 (70.0) |
| Type II | 14 (66.7) | 3 (30.0) |
| Type III | 1 (4.7) | 0 |
| Missing | 3 (14.3) | 0 |
| IRP (mmHg) | 30.9 (13-58.2); n = 9 | 26.4 (16.7-36.0); n = 2 |
| 24-hour esophageal pH monitoring | ||
| Pathological reflux | 0 | 0 |
| Acid fluid retention | 3 (14.3) | 1 (10.0) |
| Normal | 9 (42.9) | 9 (90.0) |
| Missing | 9 (42.9) | 0 |
Table 2 Procedure-related characteristics and complications
| Characteristics | DE + S (n = 21) | DE - S (n = 10) |
| Technical success | 21 (100) | 10 (100) |
| Length of tunnel (cm) | 9.3 (6-13) | 9.7 (7-12) |
| Length of myotomy (cm) | 7.1 (5-10) | 7.0 (5-10) |
| Types of myotomy | ||
| Progressive full-thickness myotomy | 17 (81.0) | 7 (70.0) |
| Full-thickness myotomy | 4 (19.0) | 3 (30.0) |
| Distance from the cardia (cm) | 1.8 (1-5) | 0 |
| Procedure time (minutes) | 61 (26-123) | 58.4 (22-128) |
| Hospital stays after operation (days) | 6.8 (4-11) | 7.0 (4-12) |
| Complications | ||
| Mucosa injury | 2 (9.5) | 0 |
| Gas-related adverse event | 0 | 0 |
| Bleeding | 0 | 0 |
Table 3 Long-term outcomes of the epiphrenic diverticulum with septum group, median (interquartile range)
| Eckardt score (n = 18) | Pre-operation | Post-operation | P value |
| Dysphagia | 3.0 (1.75-3.0) | 0 (0-1.0) | < 0.05 |
| Chest pain | 0 (0-0.25) | 0 (0-0) | 0.083 |
| Regurgitation | 2.0 (1.0-3.0) | 0 (0-1.0) | < 0.05 |
| Weight loss | 1.0 (0-3.0) | 0 (0-0) | < 0.05 |
| Eckardt score | 6.0 (4.0-8.0) | 0(0-2.0) | < 0.05 |
Table 4 Long-term outcomes of the epiphrenic diverticulum without septum group, median (interquartile range)
| Eckardt score (n =10) | Pre-operation | Post-operation | P value |
| Dysphagia | 2.5 (2.0-3.0) | 1.0 (0-1.25) | < 0.05 |
| Chest pain | 1.0 (0-1.0) | 0 (0-0.25) | < 0.05 |
| Regurgitation | 1.5 (0-2.0) | 0 (0-1.0) | < 0.05 |
| Weight loss | 2.5 (0.75-3.0) | 0 (0-0) | < 0.05 |
| Eckardt score | 6.0 (3.75-8.25) | 1.0 (0-3.0) | < 0.05 |
Table 5 Clinical reflux evaluation, n (%)
| Clinical reflux evaluation | ED + S (n = 18) | ED - S (n = 10) |
| GERD-Q score | ||
| ≥ 8 | 3 (16.7) | 2 (20.0) |
| < 8 | 15 (83.3) | 8 (80.0) |
| Endoscopic monitoring | n = 6 | n = 5 |
| Reflux esophagitis by gastroscopy | 4 (66.7) | 1 (20.0) |
| LA-A | 3 (50) | 0 |
| LA-B | 1 (16.7) | 0 |
| LA-C | 0 | 1 (20.0) |
- Citation: Hao XW, Bi YW, Wang ZM, Niu XT, Xiang JY, Su S, Li LS, Linghu EQ, Chai NL. Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique. World J Gastroenterol 2026; 32(9): 114758
- URL: https://www.wjgnet.com/1007-9327/full/v32/i9/114758.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i9.114758
